Combination Therapy Plus Fluvastatin Improves Hep C Outcome

[Guest guest]

Combination Therapy Plus Fluvastatin Improves Hep C Outcome

Whether or not a person has metabolic syndrome, new research shows that adding fluvastatin to standard Hepatitis C combination therapy improves response rates.

FLUVASTATIN ENHANCES CHRONIC HEPATITIS C TREATMENT RESPONSE IN COMBINATION WITH PEGYLATED INTERFERON-ALPHA AND RIBAVIRIN

Well-known statin could be recycled as HCV therapy supplement

Berlin, Germany, Thursday 31 March 2011: /PRNewswire/ -- New data presented today at the International Liver CongressTM confirm the antiviral activity of fluvastatin - commonly used as a cholesterol-lowering treatment - in patients with chronic hepatitis C (HCV).1

Patients had improved early and sustained virological response (EVR and SVR) when treated with the current standard of care - pegylated Interferon-alpha and ribavirin (PegIFNα/RBV) - and fluvastatin. The results show patients receiving fluvastatin and PegIFNα/RBV achieve higher rates of EVR and SVR - 75.96% and 63.46% - to those receiving placebo and PegIFNα/RBV - 61.9% and 49.52% respectively.

Continue reading this entire article:http://multivu.prnewswire.com/mnr/prne/easl/48894/

http://www.hepatitis-central.com/mt/archives/2011/04/combination_the.html